Specificities of inflammatory bowel disease in childhood

Anne M Griffiths1

  • 1IBD Program, University of Toronto, The Hospital for Sick Children, 555 University Avenue, Toronto, Ont. M5G 1X8, Canada. anne.griffiths@sickkids.ca

Insights

Paediatric Crohn's disease incidence is rising, unlike stable ulcerative colitis rates. Genetic susceptibility and diverse symptoms, including growth impairment in Crohn's disease, are key concerns for pediatric inflammatory bowel disease.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease (IBD) Epidemiology

Background:

  • Paediatric ulcerative colitis (UC) incidence remains stable, while paediatric Crohn's disease (CD) has increased.
  • Both UC and CD incidence rise from middle childhood through adolescence, with CD showing a male preponderance in early onset.
  • Familiality suggests significant genetic susceptibility in pediatric inflammatory bowel disease (IBD).

Purpose of the Study:

  • To summarize current trends and characteristics of paediatric ulcerative colitis and Crohn's disease.
  • To highlight differences in incidence, gender distribution, and symptomatology between UC and CD in children.
  • To discuss factors influencing disease presentation and potential therapeutic advancements.

Main Methods:

  • Review of epidemiological trends in paediatric IBD.
  • Analysis of clinical presentation, including gender distribution and disease extent.
  • Discussion of genetic and environmental factors in disease pathogenesis.

Main Results:

  • Paediatric CD incidence is increasing, whereas UC incidence is stable.
  • Early-onset CD shows a male predominance; paediatric UC has an equal gender distribution.
  • Childhood UC is typically extensive; paediatric CD varies in localization. Growth impairment is a frequent complication of paediatric CD.

Conclusions:

  • Significant increase in paediatric Crohn's disease necessitates further research into contributing factors.
  • Understanding genetic susceptibility is crucial for pediatric IBD pathogenesis.
  • Advancements in immunomodulatory and biologic therapies offer potential to reduce the prevalence of chronic intestinal inflammation and its complications.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...